And For Allergen’s Next Trick..Filling a $1.5 Billion Hole?
October 17, 2017 at 15:59 PM EDT
A federal judge invalidated some of the patents protecting Allergan's blockbuster eye drug, creating a $1.5 billion revenue hold the company may need to fill.
